ARKEMA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 80.98 EUR | -2.62% |
|
-4.90% | -21.36% |
| 06-26 | Redburn Atlantic Initiates Arkema at Buy | MT |
| 05-14 | Arkema: collaboration with ProLogium in batteries | CF |
Strengths
- With a P/E ratio at 10.31 for the current year and 9.05 for next year, earnings multiples are highly attractive compared with competitors.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.84 for the current period. Therefore, the company is undervalued.
- The company appears to be poorly valued given its net asset value.
- This company will be of major interest to investors in search of a high dividend stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Commodity Chemicals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -21.36% | 6.5B | - | ||
| +0.73% | 99.64B | A- | ||
| -11.98% | 58.77B | A- | ||
| +75.71% | 48.81B | B | ||
| +5.26% | 34.94B | B | ||
| +0.61% | 31.15B | A- | ||
| +3.47% | 18.62B | B- | ||
| +17.33% | 17.44B | C+ | ||
| +5.92% | 13.51B | B- | ||
| -6.67% | 12.73B | B |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- AKE Stock
- 0IB0 Stock
- Ratings Arkema
